KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,376,823 | -55.8% | 99,052 | -27.0% | 0.00% | -100.0% |
| Q2 2023 | $3,117,995 | +62.5% | 135,624 | +109.4% | 0.00% | 0.0% |
| Q1 2023 | $1,919,254 | +9.9% | 64,774 | -7.5% | 0.00% | 0.0% |
| Q4 2022 | $1,747,125 | +32.2% | 69,997 | +15.3% | 0.00% | 0.0% |
| Q3 2022 | $1,322,000 | -40.0% | 60,724 | +16.6% | 0.00% | – |
| Q1 2022 | $2,203,000 | -72.6% | 52,070 | -58.9% | 0.00% | -100.0% |
| Q4 2021 | $8,051,000 | +133.3% | 126,804 | +115.8% | 0.00% | +200.0% |
| Q3 2021 | $3,451,000 | +119.8% | 58,747 | +45.4% | 0.00% | 0.0% |
| Q1 2021 | $1,570,000 | +630.2% | 40,394 | +1066.4% | 0.00% | – |
| Q4 2020 | $215,000 | – | 3,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |